Scholtz & Company, LLC
- SEC CIK
- 0001606134
- Latest filing
- Aug 11, 2026
ABT holding history
Abbott Laboratories in every 13F filed by Scholtz & Company, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ABT overviewAll 13F holders of ABTFull Q2 2026 holdings
- Shares (Q2 2026)
- 0
- Sold out in Q2 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 21
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 0 | $0 | 0.0% | −43,877−100.0% | Sold out | Holders |
| Q1 2026 | 43,877 | $4.50M | 2.3% | −5,320−10.8% | Reduced | Holders |
| Q4 2025 | 49,197 | $6.16M | 2.7% | +1,150+2.4% | Added | Holders |
| Q3 2025 | 48,047 | $6.44M | 2.8% | +1,414+3.0% | Added | Holders |
| Q2 2025 | 46,633 | $6.34M | 2.8% | −735−1.6% | Reduced | Holders |
| Q1 2025 | 47,368 | $6.28M | 3.1% | −93−0.2% | Reduced | Holders |
| Q4 2024 | 47,461 | $5.37M | 2.6% | +5,902+14.2% | Added | Holders |
| Q3 2024 | 41,559 | $4.74M | 2.2% | +903+2.2% | Added | Holders |
| Q2 2024 | 40,656 | $4.22M | 1.8% | +33,624+478.2% | Added | Holders |
| Q1 2024 | 7,032 | $799.3K | 0.4% | −7,885−52.9% | Reduced | Holders |
| Q4 2023 | 14,917 | $1.64M | 0.8% | −19,716−56.9% | Reduced | Holders |
| Q3 2023 | 34,633 | $3.35M | 2.2% | −3,216−8.5% | Reduced | Holders |
| Q2 2023 | 37,849 | $4.13M | 2.6% | −1,326−3.4% | Reduced | Holders |
| Q1 2023 | 39,175 | $3.97M | 2.8% | −560−1.4% | Reduced | Holders |
| Q4 2022 | 39,735 | $4.36M | 3.1% | −995−2.4% | Reduced | Holders |
| Q3 2022 | 40,730 | $4.24M | 3.0% | −13,336−24.7% | Reduced | Holders |
| Q2 2022 | 54,066 | $5.87M | 3.6% | −3,115−5.4% | Reduced | Holders |
| Q1 2022 | 57,181 | $6.77M | 2.7% | +456+0.8% | Added | Holders |
| Q4 2021 | 56,725 | $7.98M | 2.6% | −18,190−24.3% | Reduced | Holders |
| Q3 2021 | 74,915 | $8.85M | 3.1% | −10,070−11.8% | Reduced | Holders |
| Q2 2021 | 84,985 | $9.85M | 3.4% | +2,035+2.5% | Added | Holders |
| Q1 2021 | 82,950 | $9.94M | 3.8% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.